Thoracic Spinal Cord Stimulation for Neuropathic Pain After Spinal Meningioma Removal: A Case Report

2009 ◽  
Vol 25 (2) ◽  
pp. 167-169 ◽  
Author(s):  
Mi Geum Lee ◽  
Sang Sik Choi ◽  
Mi Kyoung Lee ◽  
Myoung Hoon Kong ◽  
Il Ok Lee ◽  
...  
2001 ◽  
Vol 45 (4) ◽  
pp. 353 ◽  
Author(s):  
Sung Chan Jin ◽  
Seoung Ro Lee ◽  
Dong Woo Park ◽  
Kyung Bin Joo

2018 ◽  
Vol 2018 ◽  
pp. 1-5
Author(s):  
Michael G. Hillegass ◽  
Samuel F. Luebbert ◽  
Maureen F. McClenahan

We report a case in which a 34-year-old female with refractory intracranial hypotension headaches due to a spontaneous dural tear was ultimately treated with CT-guided transforaminal epidural placement of a synthetic absorbable sealant (DuraSeal®). The procedure successfully resolved her headaches; however she subsequently developed thoracic neuralgia presumably due to mass effect of the sealant material on the lower thoracic spinal cord and nerve roots. This case report describes the potential for significant spinal cord and nerve root compression as well as the development of chronic neuralgia with the placement of epidural hydrogel and fibrin glue sealants. Careful consideration should be taken into the needle gauge, needle position, injectate volumes, and injection velocity when delivering the sealant to the epidural space. Use of an 18-gauge Tuohy needle with a slow but steady injection pressure, constant patient feedback, and a conservative injectate volume (less than 2 ml per level) may best optimize sealant delivery to minimize the risk of spinal cord compression and neurologic injury.


2014 ◽  
Vol 28 (3) ◽  
pp. 282-286
Author(s):  
Osamu Kawakami ◽  
Keisuke Yamada ◽  
Masahiro Kojima ◽  
Keiko Matsubayashi ◽  
Yuichiro Tsuge ◽  
...  

2020 ◽  
Vol 39 (03) ◽  
pp. 228-231 ◽  
Author(s):  
Arthur Lopes ◽  
Kleber Duarte ◽  
Catarina Lins ◽  
Gabriel Kubota ◽  
Valquíria Silva ◽  
...  

AbstractColorectal cancer is one of the most common oncological diseases. Chemotherapy is usually recommended as an adjuvant treatment for stage-II, -III, and -IV tumors. Approximately 10% of the patients develop neuropathic pain after chemotherapy, and they may remain refractory despite the administration of drugs that are commonly used to treat neuropathic pain. Spinal cord stimulation is a good treatment option for neuropathic pain of the lower limbs, and it should be trialed in patients with chemotherapy-induced peripheral neuropathy. We report the case of a patient with oxaliplatin-induced neuropathy and neuropathic pain refractory to oral medication who was successfully treated by spinal cord stimulation.


Sign in / Sign up

Export Citation Format

Share Document